Used primarily as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of dopamine and serotonin receptor modulators. Its structure supports the creation of bioactive molecules with potential applications in treating neurological and psychiatric disorders such as depression, schizophrenia, and Parkinson’s disease. The compound's piperidine backbone and naphthyl group enhance binding affinity to central nervous system receptors, making it valuable in medicinal chemistry research. It is also employed in the preparation of selective enzyme inhibitors and receptor ligands for use in drug discovery and biochemical assays.